In clinical trials, researchers found Yeztugo to be highly effective as a twice-yearly form of pre-exposure prophylaxis.

US regulators approved an HIV drug described as a “miracle” by the UN for its ability to prevent infections with two doses a ...

The breakthrough double injection won’t be cheap in the US, although scientists argue it could (and should) be.

The Philippines is currently facing a sharp rise in HIV cases, with a staggering 500% increase reported among the youth.

“This is a historic day in the decades-long fight against HIV,” Gilead CEO Daniel O’Day said in the company’s announcement.

The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts ...

A drug called lenacapavir, administered in two injections a year, offers protection from HIV comparable to daily pills. One ...

The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported ...

The clearance ushers in a closely-watched launch for Gilead, which aims to show a long-acting injection can upend a market ...

The U.S. Food and Drug Administration has approved Yeztugo (lenacapavir), an injectable HIV-1 capsid inhibitor, as ...

But the Trump administration’s cuts to HIV programs in the U.S. and abroad could undermine the drug’s rollout.